The dynamic change of antibody index against Covid-19 is a powerful diagnostic tool for the early phase of the infection and salvage PCR assay errors

Background: Currently, PCR assay is a golden standard for diagnosis of Covid-19. However, it needs nasopharyngeal swabs, expensive instruments and expertise. It even causes PCR errors. Methods: We validated the antibody assay (Roche) in 36 followed patients and 1879 controls (medical staffs). Result...

Full description

Bibliographic Details
Main Authors: Masao Omata, Yosuke Hirotsu, Hiroki Sugiura, Makoto Maejima, Yuki Nagakubo, Kenji Amemiya, Miyoko Hayakawa, Toshiharu Tsutsui, Yumiko Kakizaki, Hitoshi Mochizuki, Yoshihiro Miyashita
Format: Article
Language:English
Published: Elsevier 2021-10-01
Series:Journal of Microbiology, Immunology and Infection
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1684118221000086
_version_ 1818896842627219456
author Masao Omata
Yosuke Hirotsu
Hiroki Sugiura
Makoto Maejima
Yuki Nagakubo
Kenji Amemiya
Miyoko Hayakawa
Toshiharu Tsutsui
Yumiko Kakizaki
Hitoshi Mochizuki
Yoshihiro Miyashita
author_facet Masao Omata
Yosuke Hirotsu
Hiroki Sugiura
Makoto Maejima
Yuki Nagakubo
Kenji Amemiya
Miyoko Hayakawa
Toshiharu Tsutsui
Yumiko Kakizaki
Hitoshi Mochizuki
Yoshihiro Miyashita
author_sort Masao Omata
collection DOAJ
description Background: Currently, PCR assay is a golden standard for diagnosis of Covid-19. However, it needs nasopharyngeal swabs, expensive instruments and expertise. It even causes PCR errors. Methods: We validated the antibody assay (Roche) in 36 followed patients and 1879 controls (medical staffs). Results: Of 1879 medical staffs, only two (0.11%) were positive by Cut off Index (COI; 1.0) (mean ± SD, 0.094 ± 0.047). Thirty six patients were composed of three groups; Group A,4 from Diamond Princess cruise ship, Group B, 2 infected in Africa, and Group C, 30 infected in Japan. PCR assays were conducted at outside laboratories before and repeated in house after hospitalized. Of 36 at admission, positive antibody was seen in 4/4 from the ship, 0/2 from Africa, and 5/30 from Japan. Two from Africa showed the increase of COI and became positive on days 8 and 13. Thirty Japanese was divided in two groups, e.g., 23 showed dynamic increase of COI up to 84.4 within 3 days while active virus replication present (Group C). In remaining 7 (7/30, 23%) (Group C'), no rise of antibody nor positive in house PCR assays, indicative of false positive results of PCR at the beginning. Conclusion: This antibody testing has a wide dynamic ranges of COI and, thus, could be utilized in the early infection phase. This may also compliment and even help to avoid possible PCR errors. Therefore, this can serve as a powerful diagnostic tool, needed in the frontline of the clinic and hospitals.
first_indexed 2024-12-19T19:06:42Z
format Article
id doaj.art-c58044cae40143e98c5c7e8a3e240724
institution Directory Open Access Journal
issn 1684-1182
language English
last_indexed 2024-12-19T19:06:42Z
publishDate 2021-10-01
publisher Elsevier
record_format Article
series Journal of Microbiology, Immunology and Infection
spelling doaj.art-c58044cae40143e98c5c7e8a3e2407242022-12-21T20:09:26ZengElsevierJournal of Microbiology, Immunology and Infection1684-11822021-10-01545830838The dynamic change of antibody index against Covid-19 is a powerful diagnostic tool for the early phase of the infection and salvage PCR assay errorsMasao Omata0Yosuke Hirotsu1Hiroki Sugiura2Makoto Maejima3Yuki Nagakubo4Kenji Amemiya5Miyoko Hayakawa6Toshiharu Tsutsui7Yumiko Kakizaki8Hitoshi Mochizuki9Yoshihiro Miyashita10Genome Analysis Center, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, Japan; The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan; Corresponding author. University of Tokyo, Yamanashi Central Hospital, Kofu, Japan. Fax: +81 55 253 8011.Genome Analysis Center, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, JapanDivision of Clinical Biochemistry and Immunology, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, JapanDivision of Microbiology in Clinical Laboratory, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, JapanDivision of Microbiology in Clinical Laboratory, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, Japan; Division of Genetics and Clinical Laboratory, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, JapanDivision of Genetics and Clinical Laboratory, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, JapanCentral Clinical Laboratory, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, JapanLung Cancer and Respiratory Disease Center, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, JapanLung Cancer and Respiratory Disease Center, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, JapanGenome Analysis Center, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, Japan; Central Clinical Laboratory, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, Japan; Department of Gastroenterology, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, JapanLung Cancer and Respiratory Disease Center, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, JapanBackground: Currently, PCR assay is a golden standard for diagnosis of Covid-19. However, it needs nasopharyngeal swabs, expensive instruments and expertise. It even causes PCR errors. Methods: We validated the antibody assay (Roche) in 36 followed patients and 1879 controls (medical staffs). Results: Of 1879 medical staffs, only two (0.11%) were positive by Cut off Index (COI; 1.0) (mean ± SD, 0.094 ± 0.047). Thirty six patients were composed of three groups; Group A,4 from Diamond Princess cruise ship, Group B, 2 infected in Africa, and Group C, 30 infected in Japan. PCR assays were conducted at outside laboratories before and repeated in house after hospitalized. Of 36 at admission, positive antibody was seen in 4/4 from the ship, 0/2 from Africa, and 5/30 from Japan. Two from Africa showed the increase of COI and became positive on days 8 and 13. Thirty Japanese was divided in two groups, e.g., 23 showed dynamic increase of COI up to 84.4 within 3 days while active virus replication present (Group C). In remaining 7 (7/30, 23%) (Group C'), no rise of antibody nor positive in house PCR assays, indicative of false positive results of PCR at the beginning. Conclusion: This antibody testing has a wide dynamic ranges of COI and, thus, could be utilized in the early infection phase. This may also compliment and even help to avoid possible PCR errors. Therefore, this can serve as a powerful diagnostic tool, needed in the frontline of the clinic and hospitals.http://www.sciencedirect.com/science/article/pii/S1684118221000086Covid-19Early diagnosisAntibody testPCR assay
spellingShingle Masao Omata
Yosuke Hirotsu
Hiroki Sugiura
Makoto Maejima
Yuki Nagakubo
Kenji Amemiya
Miyoko Hayakawa
Toshiharu Tsutsui
Yumiko Kakizaki
Hitoshi Mochizuki
Yoshihiro Miyashita
The dynamic change of antibody index against Covid-19 is a powerful diagnostic tool for the early phase of the infection and salvage PCR assay errors
Journal of Microbiology, Immunology and Infection
Covid-19
Early diagnosis
Antibody test
PCR assay
title The dynamic change of antibody index against Covid-19 is a powerful diagnostic tool for the early phase of the infection and salvage PCR assay errors
title_full The dynamic change of antibody index against Covid-19 is a powerful diagnostic tool for the early phase of the infection and salvage PCR assay errors
title_fullStr The dynamic change of antibody index against Covid-19 is a powerful diagnostic tool for the early phase of the infection and salvage PCR assay errors
title_full_unstemmed The dynamic change of antibody index against Covid-19 is a powerful diagnostic tool for the early phase of the infection and salvage PCR assay errors
title_short The dynamic change of antibody index against Covid-19 is a powerful diagnostic tool for the early phase of the infection and salvage PCR assay errors
title_sort dynamic change of antibody index against covid 19 is a powerful diagnostic tool for the early phase of the infection and salvage pcr assay errors
topic Covid-19
Early diagnosis
Antibody test
PCR assay
url http://www.sciencedirect.com/science/article/pii/S1684118221000086
work_keys_str_mv AT masaoomata thedynamicchangeofantibodyindexagainstcovid19isapowerfuldiagnostictoolfortheearlyphaseoftheinfectionandsalvagepcrassayerrors
AT yosukehirotsu thedynamicchangeofantibodyindexagainstcovid19isapowerfuldiagnostictoolfortheearlyphaseoftheinfectionandsalvagepcrassayerrors
AT hirokisugiura thedynamicchangeofantibodyindexagainstcovid19isapowerfuldiagnostictoolfortheearlyphaseoftheinfectionandsalvagepcrassayerrors
AT makotomaejima thedynamicchangeofantibodyindexagainstcovid19isapowerfuldiagnostictoolfortheearlyphaseoftheinfectionandsalvagepcrassayerrors
AT yukinagakubo thedynamicchangeofantibodyindexagainstcovid19isapowerfuldiagnostictoolfortheearlyphaseoftheinfectionandsalvagepcrassayerrors
AT kenjiamemiya thedynamicchangeofantibodyindexagainstcovid19isapowerfuldiagnostictoolfortheearlyphaseoftheinfectionandsalvagepcrassayerrors
AT miyokohayakawa thedynamicchangeofantibodyindexagainstcovid19isapowerfuldiagnostictoolfortheearlyphaseoftheinfectionandsalvagepcrassayerrors
AT toshiharutsutsui thedynamicchangeofantibodyindexagainstcovid19isapowerfuldiagnostictoolfortheearlyphaseoftheinfectionandsalvagepcrassayerrors
AT yumikokakizaki thedynamicchangeofantibodyindexagainstcovid19isapowerfuldiagnostictoolfortheearlyphaseoftheinfectionandsalvagepcrassayerrors
AT hitoshimochizuki thedynamicchangeofantibodyindexagainstcovid19isapowerfuldiagnostictoolfortheearlyphaseoftheinfectionandsalvagepcrassayerrors
AT yoshihiromiyashita thedynamicchangeofantibodyindexagainstcovid19isapowerfuldiagnostictoolfortheearlyphaseoftheinfectionandsalvagepcrassayerrors
AT masaoomata dynamicchangeofantibodyindexagainstcovid19isapowerfuldiagnostictoolfortheearlyphaseoftheinfectionandsalvagepcrassayerrors
AT yosukehirotsu dynamicchangeofantibodyindexagainstcovid19isapowerfuldiagnostictoolfortheearlyphaseoftheinfectionandsalvagepcrassayerrors
AT hirokisugiura dynamicchangeofantibodyindexagainstcovid19isapowerfuldiagnostictoolfortheearlyphaseoftheinfectionandsalvagepcrassayerrors
AT makotomaejima dynamicchangeofantibodyindexagainstcovid19isapowerfuldiagnostictoolfortheearlyphaseoftheinfectionandsalvagepcrassayerrors
AT yukinagakubo dynamicchangeofantibodyindexagainstcovid19isapowerfuldiagnostictoolfortheearlyphaseoftheinfectionandsalvagepcrassayerrors
AT kenjiamemiya dynamicchangeofantibodyindexagainstcovid19isapowerfuldiagnostictoolfortheearlyphaseoftheinfectionandsalvagepcrassayerrors
AT miyokohayakawa dynamicchangeofantibodyindexagainstcovid19isapowerfuldiagnostictoolfortheearlyphaseoftheinfectionandsalvagepcrassayerrors
AT toshiharutsutsui dynamicchangeofantibodyindexagainstcovid19isapowerfuldiagnostictoolfortheearlyphaseoftheinfectionandsalvagepcrassayerrors
AT yumikokakizaki dynamicchangeofantibodyindexagainstcovid19isapowerfuldiagnostictoolfortheearlyphaseoftheinfectionandsalvagepcrassayerrors
AT hitoshimochizuki dynamicchangeofantibodyindexagainstcovid19isapowerfuldiagnostictoolfortheearlyphaseoftheinfectionandsalvagepcrassayerrors
AT yoshihiromiyashita dynamicchangeofantibodyindexagainstcovid19isapowerfuldiagnostictoolfortheearlyphaseoftheinfectionandsalvagepcrassayerrors